Showing results (81-90 of 332) with videos related to
Sort By:
Pageof 34
Blood Cancer Journal|November 20, 2019
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMTAvichai Shimoni, Myriam Labopin, Jürgen Finke, et al.Journal of Hematology & Oncology|May 21, 2020
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Anne-Claire Mamez, Axelle Dupont, Didier Blaise, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 5, 2013
HHV-6 cell receptor CD46 expression on various cell subsets of six blood and graft sources: a prospective seriesPatrice Chevallier, Nelly Robillard, Marina Illiaquer, et al.Bone Marrow Transplantation|January 9, 2023
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Micha Srour, Tamim Alsuliman, Julien Labreuche, et al.Haematologica|April 16, 2016
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Myriam Labopin, Marie Robin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.American Journal of Hematology|April 4, 2017
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMTJonathan Canaani, Myriam Labopin, Gerard Socié, et al.Cancer|October 7, 2014
Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: results of a multicenter prospective phase 2 trialMohamad Mohty, Florent Malard, Didier Blaise, et al.Oncotarget|March 17, 2018
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantationChristelle Retière, Catherine Willem, Thierry Guillaume, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 12, 2017
Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adultsMarina Illiaquer, Berthe-Marie Imbert-Marcille, Thierry Guillaume, et al.Pageof 34